Subtype Identification of Surgically Curable Primary Aldosteronism During Treatment With Mineralocorticoid Receptor Blockade
Giovanni Pintus,Teresa Maria Seccia,Laurence Amar,Michel Azizi,Anna Riester,Martin Reincke,Jiří Widimský,Mitsuhide Naruse,Tomaz Kocjan,Aurelio Negro,Gregory Kline,Akiyo Tanabe,Fumitoshi Satoh,Lars Christian Rump,Oliver Vonend,Peter J. Fuller,Jun Yang,Nicholas Yong Nian Chee,Steven B. Magill,Zulfiya Shafigullina,Marcus Quinkler,Anna Oliveras,Bo-Ching Lee,Chin-Chen Chang,Vin-Cent Wu,Zuzana Krátká,Michele Battistel,Domenico Bagordo,Brasilina Caroccia,Giulio Ceolotto,Giacomo Rossitto,Gian Paolo Rossi
DOI: https://doi.org/10.1161/hypertensionaha.124.22721
IF: 9.8968
2024-03-27
Hypertension
Abstract:Hypertension, Ahead of Print. BACKGROUND:Current guidelines and consensus documents recommend withdrawal of mineralocorticoid receptor antagonists (MRAs) before primary aldosteronism (PA) subtyping by adrenal vein sampling (AVS), but this practice can cause severe hypokalemia and uncontrolled high blood pressure. Our aim was to investigate if unilateral PA can be identified by AVS during MRA treatment.METHODS:We compared the rate of unilateral PA identification between patients with and without MRA treatment in large data sets of patients submitted to AVS while off renin-angiotensin system blockers and β-blockers. In sensitivity analyses, the between-group differences of lateralization index values after propensity score matching and the rate of unilateral PA identification in subgroups with undetectable (≤2 mUI/L), suppressed (<8.2 mUI/L), and unsuppressed (≥8.2 mUI/L) direct renin concentration levels were also evaluated.RESULTS:Plasma aldosterone concentration, direct renin concentration, and blood pressure values were similar in non-MRA-treated (n=779) and MRA-treated (n=61) patients with PA, but the latter required more antihypertensive agents (P=0.001) and showed a higher rate of adrenal nodules (82% versus 67%;P=0.022) and adrenalectomy (72% versus 54%;P=0.01). However, they exhibited no significant differences in commonly used AVS indices and the area under the receiving operating characteristic curve of lateralization index, both under unstimulated conditions and postcosyntropin. Several sensitivity analyses confirmed these results in propensity score matching adjusted models and in patients with undetectable, or suppressed or unsuppressed renin levels.CONCLUSIONS:At doses that controlled blood pressure and potassium levels, MRAs did not preclude the identification of unilateral PA at AVS.REGISTRATION:URL:https://www.clinicaltrials.gov; Unique identifier: NCT01234220.
peripheral vascular disease